Search results for: "johnson johnson"

(728 records)
* We recommend refining your query to help us better locate the information you're seeking.

Johnson Matthey launches commercial-scale tethered catalyst offer

Now offering multi-kilogram quantities for application in commercial processes in direct response to customer demand
You need to be a subscriber to read this article.
Click here to find out more.
Regulatory
NCEs target cancer

NCEs target cancer

As the number of NCE approvals continues to rise, researchers are looking increasingly at anticancer treatments, particularly those involving new tyrosine kinase inhibitors. Dr...

Antibacterial drugs market to reach US$45.09bn globally by 2019, says new report

Asia Pacific region expected to experience the highest growth in forecast period

Intrexon buys laboratory operations from Codexis

Expands presence to Europe and increases bioproduction capabilities and capacity
You need to be a subscriber to read this article.
Click here to find out more.
Design & Build
Looking for more sustainable processes

Looking for more sustainable processes

Moving to more sustainable and productive ways of manufacturing has to be the way forward for an industry facing higher costs and a squeeze on drug pricing. Susan Birks reports

Partnership will invest US$230m to find new ways to target hard-to-treat diseases

Initiative aims to speed up discovery of new treatments for these illnesses
Ingredients
Robert MacLeod to succeed Neil Carson as Chief Executive of Johnson Matthey

Robert MacLeod to succeed Neil Carson as Chief Executive of Johnson Matthey

He is promoted from Group Finance Director

Monoclonal antibodies (mAbs) market expected to soar from $1.2bn to $24bn in six years

Untapped US markets and low cost manufacturing in Asia Pacific and Latin America will assist growth, says F&S

Johnson & Johnson Innovation expands global incubator presence to Israel

Also announces multiple, early-stage collaborations with academia and biotech

Lonza signs five-year exclusive agreement with Index Ventures

For the development and manufacture of biologics for portfolio companies

European Commission fines Johnson & Johnson and Novartis

For delaying the release of a generic painkiller

Janssen Pharmaceuticals fined US$1.6bn for misbranding

Johnson & Johnson subsidiary also filed false claims for its schizophrenia drug Risperdal
You need to be a subscriber to read this article.
Click here to find out more.
Packaging
Improving hygiene standards in the supply chain

Improving hygiene standards in the supply chain

Pallet hygiene has been the focus of a number of pharmaceutical product recalls in recent times. Jim Hardisty, Goplasticpallets.com, explains how a new generation of plastic...
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing
Becoming a leaner contract manufacturer

Becoming a leaner contract manufacturer

As competition among CMOs gets tougher, Lean Management methods can be the crucial point of difference, argues Richard Holland, Vice President of TBM’s consulting practice in...
You need to be a subscriber to read this article.
Click here to find out more.
Regulatory
Beyond the Patent Cliff

Beyond the Patent Cliff

Jackie Maguire, CEO, Coller IP, looks at the issue of patent expiry and suggests an alternative approach to making future drug innovation profitable

DCPrime and Janssen to collaborate on potential new cancer therapy

Janssen will use DCOne technology from DCPrime for dendritic cell-based cancer vaccine

Trending Articles

  1. Takara Bio extends biomanufacturing capabilities with custom enzyme manufacturing lab Its Gothenburg facility now has a manufacturing lab that can produce customised molecular biology products such as PCR and qPCR enzymes
  2. Thermo Fisher Scientific officially opens US oral solid dose testing and R&D facility The company's further expansion in the Bend, Oregon area will assist its pharmaceutical clients in the early development of oral solid dosage (OSD) forms
  3. Sativex approved in Sweden For the treatment of spasticity due to multiple sclerosis
  4. LifeArc and RDR UK launch Raremap to strengthen rare disease research collaboration The new online directory will aim to connect researchers, clinicians, charities, patient groups and industry, helping accelerate collaboration across the UK rare disease ecosystem
  5. Avacta announces license agreement with Point Biopharma Point is a clinical-stage pharmaceutical company focused on developing radioligands as precision medicines for the treatment of cancer

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy See all

You may also like

Personal Protection New immersive innovation hub near Coimbra combines safety training, product testing and collaborative R&D to support the future of workplace protection
Ansell opens AXIS Portugal to accelerate PPE innovation in Europe

Ansell opens AXIS Portugal to accelerate PPE innovation in Europe

Read more
Hi Tech Manufacturing Linking the digital twin of the mould with production data. Virtual mould and process optimisation prior to physical construction Mould Lifecycle Management as the foundation...
Gerresheimer significantly accelerates mould development in medical technology with “Digital Mold”

Gerresheimer significantly accelerates mould development in medical technology with “Digital Mold”

Read more
Manufacturing Brings decentralised, in-house DNA synthesis capabilities to researchers in a rapidly growing biotechnology market
DNA Script expands access to on-demand DNA synthesis in India through distributor agreement with Imperial Life Sciences

DNA Script expands access to on-demand DNA synthesis in India through distributor agreement with Imperial Life Sciences

Read more
Manufacturing The pharma giant is consolidating parts of its manufacturing network as it advances a $55bn US investment programme aimed at expanding domestic production of advanced medicines
Johnson & Johnson to spend up to $750m restructuring pharmaceutical supply chain

Johnson & Johnson to spend up to $750m restructuring pharmaceutical supply chain

Read more
Manufacturing ten23 health today highlights its research collaboration with dsm-firmenich, focused on expanding excipient options for parenteral biologic drug products
ten23 health expands excipient options for biologic drug development with an external collaboration

ten23 health expands excipient options for biologic drug development with an external collaboration

Read more
Design & Build The clinical-stage biotech has relocated to ARC Oxford, strengthening its R&D capabilities as it progresses clinical trials of its oncolytic immunotherapy candidate THEO-260...
Theolytics expands Oxford biotech operations with new facility to advance THEO-260 cancer immunotherapy

Theolytics expands Oxford biotech operations with new facility to advance THEO-260 cancer immunotherapy

Read more
Research & Development In discussion with Dr Kevin Robinson (KSR), Neurvati’s Dr Bruce Leuchter (BL) explores how biology-led development, better diagnosis and rare disease infrastructure could...
Precision medicine and the fight to revive neuroscience R&D

Precision medicine and the fight to revive neuroscience R&D

Read more
Manufacturing A leading biopharmaceutical manufacturer in England is realising substantial energy savings after upgrading its ageing compressed air system with Atlas Copco’s oil-free VSD+...
Pharmaceutical company cuts energy use and achieves ISO compliance with compressor and dryer upgrade

Pharmaceutical company cuts energy use and achieves ISO compliance with compressor and dryer upgrade

Read more